STX16
Basic information
Region (hg38): 20:58651272-58679526
Links
Phenotypes
GenCC
Source:
- pseudohypoparathyroidism type 1B (Strong), mode of inheritance: AD
- pseudohypoparathyroidism type 1B (Supportive), mode of inheritance: AD
- pseudohypoparathyroidism type 1B (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Pseudohypoparathyroidism, type IB | AD | Endocrine; Renal | Complications such as osteitis fibrosa cystica may be effectively treated with calcium and vitamin D therapy | Endocrine; Renal | 15537666; 17595244; 18626245; 20960161; 20538864; 21752878 |
ClinVar
This is a list of variants' phenotypes submitted to
- Pseudohypoparathyroidism type 1B (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STX16 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 19 | ||||
missense | 27 | 33 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | 4 | |||
non coding | 60 | 12 | 60 | 132 | ||
Total | 0 | 0 | 91 | 28 | 68 |
Variants in STX16
This is a list of pathogenic ClinVar variants found in the STX16 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-58651300-G-A | Pseudohypoparathyroidism type 1B | Uncertain significance (Jan 13, 2018) | ||
20-58651314-G-A | Pseudohypoparathyroidism type 1B | Uncertain significance (Jan 13, 2018) | ||
20-58651334-C-G | Pseudohypoparathyroidism type 1B | Uncertain significance (Jan 12, 2018) | ||
20-58651386-G-A | Pseudohypoparathyroidism type 1B | Uncertain significance (Jan 13, 2018) | ||
20-58651457-G-A | Pseudohypoparathyroidism type 1B | Benign (Jan 13, 2018) | ||
20-58651473-C-G | Pseudohypoparathyroidism type 1B | Benign (Jan 12, 2018) | ||
20-58651513-G-A | Pseudohypoparathyroidism type 1B | Uncertain significance (Jan 12, 2018) | ||
20-58651542-T-G | Pseudohypoparathyroidism type 1B | Uncertain significance (Jan 12, 2018) | ||
20-58651543-G-A | Pseudohypoparathyroidism type 1B | Benign (Jul 01, 2022) | ||
20-58651586-C-G | Pseudohypoparathyroidism type 1B | Benign (Jan 13, 2018) | ||
20-58651598-G-A | Pseudohypoparathyroidism type 1B | Uncertain significance (Jan 12, 2018) | ||
20-58651630-G-A | Pseudohypoparathyroidism type 1B | Uncertain significance (Jan 13, 2018) | ||
20-58651652-C-T | Pseudohypoparathyroidism type 1B | Benign (Jan 13, 2018) | ||
20-58651657-C-A | Pseudohypoparathyroidism type 1B | Benign (Jan 13, 2018) | ||
20-58651847-G-A | Pseudohypoparathyroidism type 1B | Benign (Jan 13, 2018) | ||
20-58651944-T-C | Pseudohypoparathyroidism type 1B | Benign (Jan 13, 2018) | ||
20-58651982-A-C | Pseudohypoparathyroidism type 1B | Benign (Jan 13, 2018) | ||
20-58652050-A-G | Inborn genetic diseases | Uncertain significance (May 25, 2022) | ||
20-58652105-C-T | Likely benign (May 18, 2018) | |||
20-58652106-T-TC | Uncertain significance (Jul 22, 2023) | |||
20-58652112-C-A | Pseudohypoparathyroidism type 1B | Benign/Likely benign (Jun 19, 2022) | ||
20-58652112-C-T | Inborn genetic diseases | Uncertain significance (Jan 22, 2024) | ||
20-58652152-C-A | Likely benign (Jan 16, 2024) | |||
20-58652153-G-A | Pseudohypoparathyroidism type 1B | Benign (Jan 04, 2024) | ||
20-58652371-A-AC | Benign (May 26, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STX16 | protein_coding | protein_coding | ENST00000371141 | 9 | 28255 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.483 | 0.517 | 125738 | 0 | 10 | 125748 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.952 | 160 | 198 | 0.809 | 0.0000115 | 2126 |
Missense in Polyphen | 35 | 46.14 | 0.75855 | 540 | ||
Synonymous | 0.435 | 70 | 74.8 | 0.936 | 0.00000435 | 627 |
Loss of Function | 3.19 | 4 | 19.0 | 0.210 | 0.00000102 | 208 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000123 | 0.000123 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000981 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: SNARE involved in vesicular transport from the late endosomes to the trans-Golgi network. {ECO:0000269|PubMed:18195106}.;
- Pathway
- SNARE interactions in vesicular transport - Homo sapiens (human);Nicotine Pathway (Dopaminergic Neuron), Pharmacodynamics;Ectoderm Differentiation;Vesicle-mediated transport;Membrane Trafficking;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
(Consensus)
Recessive Scores
- pRec
- 0.0823
Intolerance Scores
- loftool
- 0.632
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.99
Haploinsufficiency Scores
- pHI
- 0.824
- hipred
- N
- hipred_score
- 0.462
- ghis
- 0.591
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.863
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Stx16
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype;
Zebrafish Information Network
- Gene name
- stx16
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- increased curvature
Gene ontology
- Biological process
- intracellular protein transport;vesicle fusion;retrograde transport, endosome to Golgi;vesicle docking;Golgi ribbon formation
- Cellular component
- Golgi membrane;cytoplasm;Golgi apparatus;trans-Golgi network;cytosol;focal adhesion;endomembrane system;integral component of membrane;SNARE complex;Golgi cisterna;trans-Golgi network membrane;intracellular membrane-bounded organelle;perinuclear region of cytoplasm
- Molecular function
- SNARE binding;SNAP receptor activity;protein binding;syntaxin binding